Discussing on the nw covid variant that is lurking in the backdrop of increasing coronavirus cases, AIIMS chief has said that it is time to go aggressive with tracing, testing and isolation. All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria said that India’s battle against coronavirus is facing its current challenge as new strains appear across the world.
THE status on the health and COVID-19 is that re-infections in people who have formed antibodies to the virus are likely.
Not accepting on coronavirus herd immunity in India, Guleria said that most of the population in India requires antibodies to protect the whole population.
Some experts argued that new coronavirus mutant strains are confirmed to have been found in Amravati, Yavatmal and Akola, all in the Vidarbha region in the eastern part of the state.
They are Maharashtra Covid Task Force Member Dr. Shashank Joshi and Director of Medical Education & Research Dr. T.P. Lahane, both renowned physicians.
Lahane reported that new (mutant) strains were found in samples analysed from these three districts, but made it clear that more studies are needed to verify the possible risk of infection of the new coronavirus variant.
Joshi said that while the government has thoroughly seized and checked it in depth, some areas in the state have registered large cluster infections and a lower mortality risk.
“India needs to go back to aggressive measures of testing, contact tracing and isolating infections,” said Guleria.
Guleria said that the vaccine is the only tool possible to improve immunity and help minimise the mortality rate due to infectious diseases.
The government’s vaccine campaign focuses on establishing herd immunity by immunising a critical mass of citizens. The Government plans to immunise 3 Crore Health Employees and Frontline Staff in the first wave of vaccination. It will be accompanied by the switch of 27 crore people who are over 50 years of age or who have co-morbidities.